(1 - 14 from 15
)
Delphi Diagnostics SET2,3 Test Clarifies Therapy Options for …
www.precisiononcologynews.com
· SET2,3 and SET ER/PR were developed at MD Anderson Cancer Center by Fraser Symmans, a professor of pathology. Both have been licensed to Houston, Texas-based Delphi Diagnostics, where they are in advanced stages of development in preparation for …
sorted by relevance / date